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Abstract
Objective—To develop an ex vivo equine corneal organ culture model. Specifically, to assess the
equine cornea's extracellular matrix and cellularity after 7 days using two different culture
techniques: either (a) immersion system or (b) air/liquid interface system, to determine the best ex
vivo equine corneal model.
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Methods—Fourteen healthy equine corneas with 2 mm of perilimbal sclera were freshly
harvested from 7 horses undergoing humane euthanasia. One corneal-scleral ring (CSR) from each
horse was randomly placed in the (a) immersion condition organ culture system (IC), with the
contralateral SCR being placed in the (b) air/liquid interface organ culture system (ALC) for 7
days. All corneas were evaluated using serial daily gross photography, histology, qPCR and
TUNEL assay.
Results—CSRs placed in the IC (a) had complete loss of corneal transparency on gross
photography by 7 days, showed a significant level of corneal stromal disorganization, significantly
increased αSMA levels on qPCR, and apoptosis on TUNEL assay compared to controls. The ALC
(b), had weak stromal disorganization on histopathologic examination and was not significantly
different from normal equine corneal controls on all other evaluated parameters.
Conclusions—The air-liquid interface organ culture system maintains the equine cornea's
extracellular matrix and preserves corneal transparency, while the immersion condition results in
near complete degradation of normal equine corneal architecture after 7 days in culture. The airliquid organ culture is a viable option to maintain a healthy equine cornea in an ex-vivo setting for
wound healing studies.
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Introduction
Corneal disease in horses includes ulcerative, fungal, traumatic, and neoplastic conditions
[1]. While these diseases are currently treated with a variety of medical and surgical
modalities, permanent vision loss commonly results due to extensive corneal fibrosis.
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Equine corneal research to date has typically been performed using either in vitro model
systems [1-6] or in vivo studies utilizing a low number of animals [7-9]. In vitro models
utilize monocultures of representative corneal cell populations and cannot fully evaluate
potential pathologic and toxic changes that may occur in the multi-layered cornea. In vivo
studies that contain small sample sizes may fail to prove significance due to low statistical
power. It is desirable for in vitro research to be validated in vivo prior to routine clinical
application of a new treatment. As such, ex vivo models represent a valuable bridge between
in vitro and in vivo research.

Ex vivo models have been used to study a variety of different ocular diseases [10-16] in
different species [14, 17-19]. One important benefit of an ex vivo model is that it allows for
a more adequate representation of in vivo conditions. Successful corneal ex vivo models
maintain normal corneal architecture, extra-cellular matrix, and different cell populations
normally present within the living cornea. Additionally, ex vivo models are financially
prudent, highly reproducible, and often require less regulatory approval when compared to
in vivo experiments.
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To our knowledge, no ex vivo model for the equine cornea exists. The goal of this study was
to develop an ex vivo equine corneal model that would be highly reproducible. Two different
types of ex vivo model systems were selected for study due to their previous successful use
in other animals [17, 20, 21]. We sought to examine an immersion organ culture system (IC)
or an air/liquid interface organ culture system (ALC). We hypothesized that ALC would be
superior at preserving normal equine corneal architecture and demonstrate minimal cellular
apoptosis when compared to the IC.

Materials and Methods
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Approval for this study was obtained by the University of Missouri Institutional Animal
Care and Use Committee. A total of seven horses donated to the University of Missouri were
humanely euthanized for reasons unrelated to this study. The median age of all horses was
17 years (range 14-22 years). Breeds included 4 Quarter horses, 2 Appaloosas and 1
Belgian. Prior to euthanasia, all horses had slit-lamp biomicroscopy (SL-15 Biomicroscope,
Kowa Inc, Tokyo, Japan) performed OU by a board-certified veterinary ophthalmologist
(EAG) and were deemed free of anterior segment disease.
Immediately following humane euthanasia, the ocular surface was washed with a 1% dilute
betadine solution. The cornea along with the surrounding 2-3 mm of peri-limbal sclera was
harvested by making a stab incision into the sclera with a Bard-Parker #11 blade (Aspen
Surgical, Caledonia, MI) and then continuing the incision around the peri-limbal sclera with
Stevens tenotomy scissors (Integra Miltex, Plainsboro, NJ). Once the cornea and
surrounding sclera (corneal-scleral ring, CSR) was harvested, the CSRs were immediately
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placed into a sterile 50 ml test tube filled with 20 ml of modified eagle medium (Life
technologies, Carlsbad, CA), placed on ice, and promptly transported to the laboratory. Once
at the laboratory, the test tube was opened under a cell culture hood and the contents placed
into a sterile petri dish. Any remaining peri-limbal conjunctiva was removed at that time
with sterile Stevens tenotomy scissors and the CSR was again washed with a 1% betadine
solution followed by copious rinsing with sterile phosphate buffer solution (PBS). A coin
toss was utilized to randomly assign the CSRs into one of two culture systems (e.g. IC or
ALC).
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For the IC, the CSR was sterilely placed into a 50 ml tissue culture plate (Corning Life
Sciences, Corning, NY) epithelial side up. The tissue culture plate was then filled with 15
mls of MEM media supplemented with 10% fetal bovine serum, essential amino acids,
penicillin, streptomycin, fungizone, sodium pyruvate and MEM vitamins. All culture media
reagents were provided by Life technologies Carlsbad, California. Following application of
media the CSR was visibly inspected to ensure it was completely submerged. The total
culture media was changed once daily.
For the ALC, the CSR was placed onto a specially constructed corneal conformer (Figure 1)
that was designed to maintain the normal corneal curvature of the equine cornea without
appling any unequal force to the corneal endothelium. The CSR and conformer were placed
into a 50 ml tissue culture plate, 13 mls of culture media was added such that the corneal
endothelium was continually bathed in culture media but a 10 mm diameter area of axial
equine cornea was exposed to air. Media was changed daily and the exposed axial cornea
received one drop of media three times daily (every 8 hours) to prevent corneal desiccation.
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All CSRs were cultured at 37° C in 5% CO2 for 7 days. CSRs were evaluated daily for gross
evidence of either bacterial or fungal contamination, and were photographed. After 7 days in
culture, the CSRs from both model systems were sectioned and one half placed into 10%
neutral buffered formalin for histological analysis and the other half frozen with optimal
cutting medium and placed in −80°C until further analysis was performed. All model system
corneas were compared histologically, through TUNEL assay, and by qPCR against healthy
corneas from 4 normal control horses that were humanely euthanized for reasons other than
ocular disease and processed immediately after harvesting.
Corneal Transparency
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Gross photography was performed daily using a Nikon D300s camera (Nikon, Melville,
New York). Corneal transparency of both model systems was evaluated by placing CSRs
into a sterile petri dish and then placing the sterile petri dish over a single line of 11 point
Arial font. The corneas were determined to be “opaque” (lost all corneal transparency) when
the font was no longer able to be read through the axial stroma [17].
Histopathologic Evaluation
Corneal sections were routinely processed for histological evaluation with haematoxylin and
eosin staining. All sections were evaluated by the primary author (TM) and graded by using
a scale similar to that utilized in Janin et. al where 0=no stromal disorganization, 1=weak
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stromal disorganization, 2=moderate stromal disorganization, 3=strong stromal
disorganization [17].
Real-time polymerase chain reaction detection (qPCR)
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At study end-point, sections of axial cornea weighing 1 gram or less were taken from all
CSRs in both models and individually frozen at −80°C until total RNA could be extracted.
For RNA extraction, each sample of cornea was placed into liquid nitrogen with 500 μl RLT
buffer (RNeasy kit , Qiagen, Valencia, CA) and 1% β-mercaptoethanol. This mixture was
then ground into a fine powder using a mortar and pestle, placed in a QIAshredder column
(RNeasy kit, Qiagen, Valencia, CA) on ice and processed according to manufacturer's
instructions. All corneas had qPCR performed evaluating for α-SMA. The forward primer
for α-SMA was TGGGTGACGAAGCACAGAGC and the reverse primer was
CTTCAGGGGCAACACGAAGC. This procedure was performed using a Step One Plus
real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) utilizing a 20 μl mixture
containing 2 μl cDNA, 2 μl forward (200 nM) and 2 μl reverse (200 nM) primer, and 10 μl of
2X SYBR green super mix (Bio-Rad Laboratories, Hercules, CA). This master mix was
performed at a universal cycle (95 °C for 10 min, 40 cycles at 95 °C for 15 s, and 60 °C for
60 s) according to the manufacturer's instructions [22]. β-actin was used as the housekeeping
gene with the forward primer being CGGCTACAGCTTCACCACCA and the reverse primer
being CGGGCAGCTCGTAGCTCTTC. These primers had previously been validated on
equine corneal cells [1, 4]. The efficacy of each primer was determined by using each PCR
primers expression ratio. From this, a fold change was then calculated using the 2−ΔΔCT
ratio.
TUNEL Analysis
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A TUNEL kit (ApopTag Plus In Situ Apoptosis Fluorescein Detection Kit; Millipore,
Billerica, MA) was utilized for all TUNEL testing in accordance with manufacturer's
instructions [23, 24]. Briefly, all tissue sections had an application of equilibrium buffer
followed by an application of TdT enzyme which was incubated together with the corneal
cryosection for 1 hour at 37°C in a humidified chamber. These corneal cryosections then had
an application of the stop solution consisting of Apop taq R mixed with water, followed by a
PBS wash. Anti-digoxigenin Rhodamine was applied and the slides were counterstained
with Vectashield Mounting Medium containing DAPI (Vector labs, United Kingdom) [24].
The number of cells exhibiting apoptosis as indicated by having a red nucleoli on
fluorescence were counted in 5 10x fields per corneal cryosection and averaged for statistical
analysis.
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Statistical Analysis
A Mann-Whitney test was used to determine significance for all gross photography and
histologic results. Statistical analysis of PCR and TUNEL data was performed using a oneway ANOVA and Tuckey's test. A P-value of equal to or less than 0.05 was considered
significant.
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Results
Corneal Transparency
Analysis of corneal transparency was determined if A) the sample was still transparent
yielding a value of 0 for statistical analysis or B) the sample was opaque (unable to clearly
visualize the Arial font) and therefore given a value of 1. At the end of the culture period all
corneas in the IC had a uniform loss of corneal transparency (Figure 2). This was in stark
contrast to corneas in ALC which ubiquitously maintained the natural transparent state of
the equine cornea. Differences between the IC and the ALC were significant (p<0.01).
Histological Evaluation
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Histological evaluation of all healthy control corneas yielded a grade 0. IC corneas
uniformly had complete loss of the corneal epithelium, breaks in descemet's membrane and
severe corneal edema (grade 3) which resulted in an overall loss of the normal corneal
architecture (Figure 3b). Histological evaluation of ALC corneas yielded the following: 3
receiving a grade 0, and 4 receiving a grade 1. For grade 1 corneas there was mild corneal
edema which minimally disrupted the corneal architecture (Figure 3c). Corneas from the
ALC (both grade 0 and grade 1) had both their corneal epithelium and endothelium intact at
the end of the culture period. A significant difference between IC corneas was detected
between both controls (p<0.01) and ALC corneas (p<0.01). No significant difference
between the ALC model and control group corneas was identified (p=0.073).
Real-time PCR
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Real-time PCR was performed on all samples evaluating for α-SMA. IC corneas showed a
significant increase in α-SMA levels in comparison to controls (p<0.01). The magnitude of
this increase was levels of α-SMA nearly seven times higher than that found in healthy
control corneas. Significantly increased α-SMA levels were found in IC corneas when
compared to the ALC corneas (p<0.01). Corneas from the ALC had higher α-SMA levels
than controls, but the results were not significant (p=0.749) (Figure 4).
TUNEL
On TUNEL evaluation an increased level of cellular apoptosis was found in IC corneas
(Figure 5b) compared to controls (Figure 5a), these results were significant (p<0.01) Results
of ALC corneas (Figure 5c) and control corneas showed no significant difference (p=0.899).

Discussion
Author Manuscript

Our data suggests that the air-liquid interface organ culture system better preserves the
equine cornea when compared to the immersion condition organ culture system. We were
able to adequately maintain the integrity of the equine corneal epithelium, stroma, and
endothelium using the ALC with only minimal corneal edema present at study endpoint. By
contrast, corneas in the IC had severe distortion of both the cellular and extracellular
components of the equine cornea which resulted in a complete loss of corneal transparency
and overall corneal architecture.
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Since the corneal epithelial cells are nourished through the ocular tear film, one of the main
challenges of any ex vivo corneal model is mimicking the constant blinking that allows for
uniform distribution of the pre-corneal tear film. Previous studies have tried to resolve this
issue by either developing a mechanical means of mimicking blinking through the use of a
superfusion apparatus [25]. With the use of this machine the investigator is able to maintain
a desired temperature, the corneas exposure to media, and artificial tear flow all while in a
sterile environment. Other investigators have developed mechanical arms allowing for the
eyelid to be pulled over the cornea after a drop was administered to mimic a blink [26].
Another route of maintaining adequate nutrition to the corneal epithelium is by placing the
entire model on a rocker that allows for the organ culture media to periodically flow over the
entire cornea at a desired rate [20]. In the paper by Deshpande et. al it was shown that
rocking media over the entire cornea allowed for an extension of the model's life by up to 4
weeks when compared to static controls that only received a topical application of media
once daily. This current study differed from this afore mentioned study, as we elected to treat
the air/liquid cornea multiple times a day, thereby providing more nutrition to the corneal
epithelium and preventing corneal desiccation. While we cannot directly compare our study
which was a week in duration and in a different animal species with the study that was 4
weeks in duration [20], on histopathologic evaluation we found similar results with regards
to overall corneal architecture and thickness of the corneal epithelium.
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While the IC has been utilized for human limbal cell culture models [21], our study results
do not support the use of this model for a complete equine corneal ex vivo model system.
The corneal stroma is maintained in a state of relative detrugesence through the corneal
epithelium and endothelium providing a barrier to fluid entering into the cornea and the
corneal endothelium utilizes a Na+/K+ pump to efficiently remove fluid from the corneal
storma [27]. In all IC corneas there was a relative absence of corneal epithelium, which
likely resulted in the corneal stroma being constantly exposed to the organ culture media.
Cottlier described that a loss of either the corneal epithelium or endothelium resulted in a
200% or 500% increase in corneal thickness, respectively [28]. The severe corneal edema
we observed resulted in overall loss of gross transparency in all IC corneas. The loss of the
epithelium seen in this study likely also initiated the multifaceted process of corneal wound
healing. This could explain the nearly seven fold increase in α-SMA, a known cellular
cytokine indicative of corneal fibroblast to myofibroblast transformation [29] when
compared to controls.
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A common problem with corneal ex vivo model systems is that while they include all layers
of the cornea and the extracellular matrix, damage to the fragile corneal endothelium is not
uncommon with time. In the ex vivo ALC model described in this paper, we noted that as
with other published corneal ex vivo model systems, there was some histological evidence of
endothelial damage where the corneal conformer directly contacted the corneal endothelium.
However, in the axial cornea of the ALC group the corneal endothelium did not appear
broken or damaged and was still attached to Descemet's membrane on histopathology.
Additionally, the corneal endothelium did not have a significant positive fluorescence on
TUNEL assay indicating minimal apoptosis was present at study endpoint. Our ALC model
system for equine corneas appears to afford similar endothelial protection as observed in
other successful ex vivo models in various species [14, 30].
Vet Ophthalmol. Author manuscript; available in PMC 2018 July 01.
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Ex vivo corneal models have been utilized to study a variety of different diseases in both
veterinary and physician ophthalmology. A recent paper by Harman et. al utilized a similar
ALC canine corneal model to study acute keratitis from a CHV-1 outbreak [18]. Another
paper by Bhasker et. al examined the use of a bovine ex vivo model to evaluate the
protective effects of nanoformulated therapeutics [19]. In physician ophthalmology there is a
move to eliminate the Draize test due to animal welfare concerns [31]. As a result there is a
rise in the use of ex vivo corneal models used to study the effects of different compounds on
the eye [10]. Our goal is to utilize the best possible equine corneal ex vivo model to study
equine corneal disease. Our laboratory currently has experiments underway evaluating the
fibrotic response of ex vivo equine corneas after applying an alkaline burn. Other potential
applications of the ALC model include the investigation of different topical treatments for
bacterial or fungal keratitis. Finally, this equine ex vivo model could be used to determine
different corneal drug toxicities prior to direct application.
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Our data indicates that the IC is an inappropriate model to study the equine cornea due to
rapid corneal deterioration. By contrast, the ALC preserves near normal equine corneal
structure and function for 7 days. Future studies aimed at utilizing the ALC ex vivo model to
study equine corneal fibrosis are currently underway by our laboratory.
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Figure 1.

Plastic conformer utilized for ALC in our study. Given the large size of the equine cornea,
we found this conformer helpful in maintaining the normal corneal curvature.
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Figure 2.

Photo documentation of equine corneal transparency. (A) ALC cornea Day 0; (B) IC cornea
Day 0; (C) ALC cornea Day 7; (D) IC cornea Day 7; Notice that the IC cornea has near
complete loss of transparency, while the ALC cornea has good preservation of corneal
transparency at study endpoint.
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Figure 3.

Representative histological corneal images stained with H & E staining: (A) Healthy equine
corneal control; (B) IC cornea on day 7. Complete loss of corneal epithelium along with
severe stromal edema; (C) ALC cornea on day 7; corneal epithelium is still intact and only
mild to moderate corneal edema is present.
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Figure 4.

Graph representing mRNA values from PCR of a-Smooth Muscle Actin (error bars indicate
standard deviation). Note that both the control and ALC corneas are similar in value while
the IC cornea had significantly higher aSMA values.
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Figure 5.

Representative corneal images stained by TUNEL assay. (A) Healthy control; (B) IC cornea
on Day 7; note the large areas of red nuclei indicating apoptotic bodies. (C) ALC cornea on
Day 7; note that the cornea is minimally affected with apoptotic bodies.
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